White Paper: The Cost of Quality in the Specialty Pharmaceutical Supply Chain
By Ruediger Lomb |
Quality vs Expenditure: Are you willing to risk it all?
As R&D focus shifts towards high-precision, low-volume therapies comprising of expensive and sensitive shipments, what are the repercussions of a temperature excursion or delayed delivery? The impact can be broad and far-reaching, resulting in compounded inefficiencies and increased costs throughout the entire pharmaceutical chain, ultimately affecting the patient relying on timely treatment.
Discover how to create a new quality mindset which enables not only a more robust management system, but can add value for your organization and generate better patient outcomes.